53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes
- 1 March 2013
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 128 (3) , 493-499
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- BRCA1 Functions Independently of Homologous Recombination in DNA Interstrand Crosslink RepairMolecular Cell, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Regulation of DNA End Joining, Resection, and Immunoglobulin Class Switch Recombination by 53BP1Molecular Cell, 2011
- Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cellsProceedings of the National Academy of Sciences, 2011
- 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancersNature Structural & Molecular Biology, 2010
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA BreaksCell, 2010
- 53BP1 facilitates long-range DNA end-joining during V(D)J recombinationNature, 2008
- Distinct Roles of Chromatin-Associated Proteins MDC1 and 53BP1 in Mammalian Double-Strand Break RepairMolecular Cell, 2007
- DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumoursOncogene, 2007
- Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumorsNature Medicine, 2003